Exoskeleton-Assisted Therapy for Stroke
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new robotic therapy tool called Harmony, designed to assist stroke survivors with arm movements. The goal is to make rehabilitation easier and more effective by using two special techniques: the SA controller (Synergy Avoidance controller) and the TA controller (Task Assistance controller), which ensure proper movement patterns. The trial targets individuals who experienced a stroke within the past one to six months and have moderate to severe arm impairment. Harmony could potentially improve daily activities and quality of life for participants.
As an unphased trial, this study offers a unique opportunity to contribute to innovative rehabilitation research that could enhance recovery for future stroke survivors.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the Harmony exoskeleton is safe for stroke rehabilitation?
Research shows that exoskeleton devices, like the Harmony used in this trial, are generally safe and well-tolerated for people recovering from a stroke. Studies on similar robotic devices have demonstrated improvements in walking speed, endurance, and balance for stroke patients. This suggests that these devices can be safely included in rehabilitation programs.
The Harmony exoskeleton, used with the Synergy Avoidance (SA) controller being tested, is designed to guide correct arm movements and prevent abnormal patterns that can occur after a stroke. Although specific safety data for the SA controller is not yet available, research on similar technology suggests it is safe.
In summary, while direct safety data for the SA controller is limited, the underlying technology has proven safe and helpful in similar situations.12345Why are researchers excited about this trial?
Researchers are excited about exoskeleton-assisted therapy for stroke because it introduces a new way to aid recovery by using robotic technology. Unlike traditional physical therapy, which relies on manual guidance and exercises, this therapy uses an exoskeleton equipped with a synergy assistance (SA) controller. This controller offers precise support by adjusting to the patient’s movements in real-time, potentially enhancing motor learning and recovery. By integrating advanced robotics, the therapy aims to offer more personalized and effective rehabilitation, potentially speeding up recovery and improving outcomes for stroke survivors.
What evidence suggests that this exoskeleton-assisted therapy is effective for stroke rehabilitation?
Studies have shown that the Harmony exoskeleton, which uses a special controller called Synergy Avoidance (SA), can aid in stroke recovery. In this trial, participants will test the SA controller, which stops abnormal movements and encourages normal, healthy ones. This process helps patients practice tasks correctly, crucial for recovery after a stroke. Research indicates that robotic exoskeletons like the Harmony support joint movement and overall physical recovery. As a result, the exoskeleton could help patients regain their ability to perform daily activities after a stroke.13456
Who Is on the Research Team?
Brittney C Muir, PhD
Principal Investigator
VA Puget Sound Health Care System Seattle Division, Seattle, WA
Are You a Good Fit for This Trial?
This trial is for stroke survivors over 18 who fit within the Harmony exoskeleton's size limits. Participants should have moderate to severe upper limb impairment, as measured by a specific score, and must have had their stroke recently (1 week to 6 months prior). Those with unstable health conditions, severe joint pain in the limbs, cognitive or language barriers, multiple strokes, seizures or significant communication issues cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Early Testing
Up to 5 participants testing the SA controller in one visit
Treatment
Participants complete high repetitions of reaching tasks once per day while wearing the Harmony exoskeleton for three weeks
Follow-up
Participants are monitored for changes in joint coordination and compensatory strategies after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- SA controller
- TA controller
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor